Mazowiecki Szpital Bródnowski Śródmiejskie Centrum Kliniczne

At Mazowiecki Szpital Bródnowski Śródmiejskie Centrum Kliniczne in Warsaw, the clinical trial program focuses on cardiovascular diseases, especially serious forms of myocardial infarction and acute heart failure. The studies are designed to explore new ways to reduce heart-related complications and improve outcomes for patients during and after urgent hospital care.

• Evaluating whether early treatment can lower the risk of cardiovascular death and worsening heart failure in hospitalized patients
• Testing a new anti-inflammatory approach for people recovering from ST-elevation and non-ST-elevation myocardial infarction

This research reflects a strong interest in both improving treatment effectiveness and better controlling inflammation-linked cardiovascular risk.

The site is also involved in trials centered on acute heart failure and acute myocardial infarction, with a practical goal of finding therapies that can support recovery soon after hospitalization. These studies look at whether adding new treatments to standard care can help prevent major heart events and stabilize patients more effectively.

• Assessing a treatment for patients stabilized after hospitalization for acute heart failure
• Studying a therapy aimed at reducing major adverse events after heart attack

The research combines treatment effectiveness and prevention of future cardiovascular events, making it relevant for both acute care and longer-term heart health.